Results 111 to 120 of about 13,610 (191)

Silica nanovehicles endow arsenic trioxide with an ability to effectively treat cancer cells and solid tumors

open access: yes, 2014
Arsenic trioxide is a clinical drug that can be used to successfully treat acute promyelocytic leukemia. However, its therapeutic effect on solid tumors is limited because of the poor pharmacokinetics and dose-limiting toxicity.
Zhang, Hui   +12 more
core  

FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF

open access: yes, 2005
The present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).

core  

Acute kidney injury after treatment with arsenic trioxide. [PDF]

open access: yesClin Nephrol Case Stud
Najar H   +4 more
europepmc   +1 more source

Arsenic trioxide allosterically inhibits human telomerase, validated by in-silico and in-vitro cancer and non cancer cell lines. [PDF]

open access: yesSci Rep
Chaudhary A   +8 more
europepmc   +1 more source

Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia. [PDF]

open access: yesJ Transl Med
Dutta D   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy